glp-1 agonist PDB-101: Molecule of the Month: Receptor Agonists GLP-1 receptor agonists – How

In April 2005 the US Food and Drugs Administration (FDA) approved a synthetic version, called exenatide, to treat type 2 diabetic patients unable to sufficiently control their blood sugar levels with other diabetic medications like metformin, and sulfonylureas

Dual Therapy With Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntingtons Disease

In 2022, the World Health Assembly endorsed five global diabetes coverage targets to be achieved by 2030

Dulaglutide consists of two GLP-1 molecules fused at their C-termini to a human Fc fragment of immunoglobulin G4 (IgG4) via a glycine and serine-based spacer

A systematic review and dose-response meta-analysis showed that the Garcinia cambogia supplement significantly reduced BM (body weight), BMI (body mass index), PFM (percentage of fat mass), and WC (waist circumference)

The SURPASS-5 study assessed the efficacy and safety of an injectable combination therapy combining tirzepatide with insulin glargine (75)